Shares of NuVasive jumped after the spinal device company forecast fourth-quarter and 2014 results that were better than analysts expected.

The San Diego company said it will report about $189 million in revenue for the fourth quarter, up 14 percent from the year-ago period. For the full year it said revenue grew 10 percent to about $683 million, and it expects sales to rise to $725 million in 2014.